In NOZ cells, acylcarnitine upregulates m6A methylation levels in a dose-dependent manner by decreasing the expression of ALKBH5 and increasing the level of METTL3, thereby stabilizing lncBCL2L11 expression [44]
Additionally, while a plateau in weight loss was observed in the placebo group at week 18, weight-loss with cagrilintide continued throughout the 26 weeks
[25] [26] These medications are not recommended during pregnancy or breastfeeding and should be used with caution in people with severe gastrointestinal disorders such as gastroparesis
The effectiveness of these medications depends not only on consistent dosing but also on proper injection technique and site selection
Digestive Tolerance Evaluations Treatment response may vary significantly depending on metabolism, hydration support, digestive sensitivity, and healthcare consistency
Some people with type 2 diabetes use basal insulin alone or with other glucose-lowering medicines, depending on their care plan
